Novartis $2m gene therapy for rare disorder is world's most expensive drug
Swiss drugmaker Novartis on Friday won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million.
from bdnews24.com - Home http://bit.ly/2X5Bb8j
from bdnews24.com - Home http://bit.ly/2X5Bb8j
No comments